Additional file 1 of The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

Additional file 1: Supplementary Fig. 1. Uptake of 18F-fluorodeoxyglucose measured in patients included in the pilot phase of the study (n = 12), in which Pre-SUV, Mid-SUV (2 weeks after initiation of CRT), and Post-SUV (3 weeks after completion of CRT) were determined. Mid-SUV was not significantly different from Pre-SUV and Post-SUV (P = 0.215 and P = 0.4068, respectively).

附加文件1：补充图1。本研究先导阶段纳入的12例患者中检测的18F-氟脱氧葡萄糖（18F-fluorodeoxyglucose）摄取情况，该阶段中测定了标准摄取值（Standardized Uptake Value，SUV）相关指标：治疗前SUV（Pre-SUV）、同期放化疗（CRT，chemoradiotherapy）启动后2周的中期SUV（Mid-SUV）以及同期放化疗完成后3周的末期SUV（Post-SUV）。中期SUV与治疗前SUV及末期SUV均无显著统计学差异（分别为P=0.215和P=0.4068）。